James J Schlesselman

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint Phase II clinical trials in oncology: strengths and limitations of two-stage designs
    James J Schlesselman
    Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pennsylvania 15213, USA
    Cancer Invest 24:404-12. 2006
  2. ncbi request reprint The emerging case-control study: lung cancer in relation to tobacco smoking
    James J Schlesselman
    Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Prev Med 43:251-5. 2006
  3. ncbi request reprint [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Berna, Switzerland
    Gac Sanit 22:144-50. 2008
  4. ncbi request reprint Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    Epidemiology 18:805-35. 2007
  5. pmc Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    PLoS Med 4:e297. 2007
  6. ncbi request reprint Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Leiden University Medical Center, Leiden, The Netherlands
    Ann Intern Med 147:W163-94. 2007
  7. ncbi request reprint Family history of cancer, oral contraceptive use, and ovarian cancer risk
    Gail R Walker
    Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Florida, USA
    Am J Obstet Gynecol 186:8-14. 2002
  8. ncbi request reprint Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk
    Rakesh Singal
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue D8 4, Ste 3300, Miami, FL 33136, USA
    Int J Oncol 25:1465-71. 2004
  9. ncbi request reprint Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer
    Luis E Raez
    Division of Hematology Oncology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, 1475 NW 12 Ave 3510, Miami, FL 33136, USA
    J Clin Oncol 22:2800-7. 2004
  10. ncbi request reprint Safety concerns and health benefits associated with oral contraception
    Ronald Burkman
    Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 190:S5-22. 2004

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Phase II clinical trials in oncology: strengths and limitations of two-stage designs
    James J Schlesselman
    Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pennsylvania 15213, USA
    Cancer Invest 24:404-12. 2006
    ..These points are discussed in context of the role of Phase II clinical trials in the development of new treatments for cancer...
  2. ncbi request reprint The emerging case-control study: lung cancer in relation to tobacco smoking
    James J Schlesselman
    Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Prev Med 43:251-5. 2006
    ..The exceptionally high relative risk of lung cancer that was found has had far-reaching medical, social, and economic consequences...
  3. ncbi request reprint [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Berna, Switzerland
    Gac Sanit 22:144-50. 2008
    ..We hope that the STROBE statement will contribute to improving the quality of reporting of observational studies...
  4. ncbi request reprint Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    Epidemiology 18:805-35. 2007
    ..Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated web site (http://www.strobe-statement.org) should be helpful resources to improve reporting of observational research...
  5. pmc Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    PLoS Med 4:e297. 2007
    ..Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated Web site (http://www.strobe-statement.org/) should be helpful resources to improve reporting of observational research...
  6. ncbi request reprint Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Leiden University Medical Center, Leiden, The Netherlands
    Ann Intern Med 147:W163-94. 2007
    ..Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated Web site (www.strobe-statement.org) should be helpful resources to improve reporting of observational research...
  7. ncbi request reprint Family history of cancer, oral contraceptive use, and ovarian cancer risk
    Gail R Walker
    Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Florida, USA
    Am J Obstet Gynecol 186:8-14. 2002
    ....
  8. ncbi request reprint Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk
    Rakesh Singal
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue D8 4, Ste 3300, Miami, FL 33136, USA
    Int J Oncol 25:1465-71. 2004
    ..0-0.7) and earlier stage disease (aOR=0.3 for stage III versus II, 95% CI: 0.3-2.6). These findings suggest that polymorphisms of the MTHFR gene may alter the risk of developing prostate cancer...
  9. ncbi request reprint Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer
    Luis E Raez
    Division of Hematology Oncology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, 1475 NW 12 Ave 3510, Miami, FL 33136, USA
    J Clin Oncol 22:2800-7. 2004
    ..To determine the safety, immunogenicity, and clinical response to an allogeneic tumor vaccine for non-small-cell lung cancer, we conducted a phase I trial in patients with advanced metastatic disease...
  10. ncbi request reprint Safety concerns and health benefits associated with oral contraception
    Ronald Burkman
    Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 190:S5-22. 2004
    ..Some of these benefits include reduction in menstrual-related symptoms, fewer ectopic pregnancies, a possible increase in bone density, and possible protection against pelvic inflammatory disease...
  11. ncbi request reprint Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma
    Luis E Raez
    Department of Medicine, University of Miami School of Medicine, Miami, FL 33136, USA
    Cancer Gene Ther 10:850-8. 2003
    ..The positive clinical outcome suggests that nonimmunogenic tumors may be highly susceptible to immune effector cells generated by immunization...
  12. ncbi request reprint [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Berna, Suiza
    Rev Esp Salud Publica 82:251-9. 2008
    ..We hope that the STROBE statement will contribute to improving the quality of reporting of observational studies...